Coloplast A/S
CLPBF
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.93B
Close$
Share Statistics
| Market cap | $13.93 Billion |
|---|---|
| Enterprise Value | $36.91 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 15.12% |
|---|---|
| Return on Assets | 4.31% |
| Return on Invested Capital | 14.88% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.62 |
| Enterprise Value to EBIT | 6.16 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 1.78 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Coloplast AS
16,907 employees
CEO: Kristian Villumsen Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Vo...